FELIX BAKER Insider Trading $GEVA SYNAGEVA BIOPHARMA CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FELIX BAKER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FELIX BAKER. FELIX BAKER is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in Mirati Therapeutics, Inc. ($MYG).
FELIX BAKER in SYNAGEVA BIOPHARMA CORP
Trading Symbol: GEVAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of FELIX BAKER: Director
Holdings: 9,184,771 shares
Latest Transaction: Jan 09 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of FELIX BAKER in SYNAGEVA BIOPHARMA CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, IBPI, BCRX, GHDX, MYG, SGEN, GEVA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | P | 94.19 | 1,000,000 | 94,190,000 | 9,184,771 | 8.2 M to 9.2 M (+12.22 %) |
Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 60.45 | 4,250 | 256,913 | 0 | |
Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 60.45 | 4,250 | 256,913 | 0 | |
Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 60.45 | 4,250 | 256,913 | 0 | |
Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 60.45 | 4,250 | 256,913 | 0 | |
Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 60.45 | 4,250 | 256,913 | 0 | |
Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 60.45 | 4,250 | 256,913 | 0 | |
Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 60.45 | 4,250 | 256,913 | 0 | |
Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 60.45 | 4,250 | 256,913 | 223,864 | 219.6 K to 223.9 K (+1.94 %) |
Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 60.45 | 4,250 | 256,913 | 8,184,771 | 8.2 M to 8.2 M (+0.05 %) |
Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 60.45 | 4,250 | 256,913 | 112,740 | 108.5 K to 112.7 K (+3.92 %) |
Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 60.45 | 4,250 | 256,913 | 1,748,315 | 1.7 M to 1.7 M (+0.24 %) |
Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 60.45 | 4,250 | 256,913 | 67,729 | 63.5 K to 67.7 K (+6.70 %) |
Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 60.45 | 4,250 | 256,913 | 177,463 | 173.2 K to 177.5 K (+2.45 %) |
Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 60.45 | 4,250 | 256,913 | 219,050 | 214.8 K to 219.1 K (+1.98 %) |
Jun 06 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 80.35 | 15,000 | 1,205,250 | 15,000 | |
Apr 25 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 65.10 | 8,000 | 520,800 | 0 | |
Apr 25 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 65.10 | 8,000 | 520,800 | 0 | |
Apr 25 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 65.10 | 8,000 | 520,800 | 0 | |
Apr 25 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 65.10 | 8,000 | 520,800 | 0 | |
Apr 25 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 65.10 | 8,000 | 520,800 | 0 | |
Apr 25 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 65.10 | 8,000 | 520,800 | 0 | |
Apr 25 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 65.10 | 8,000 | 520,800 | 0 | |
Apr 25 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 65.10 | 8,000 | 520,800 | 219,614 | 211.6 K to 219.6 K (+3.78 %) |
Apr 25 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 65.10 | 8,000 | 520,800 | 8,180,521 | 8.2 M to 8.2 M (+0.10 %) |
Apr 25 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 65.10 | 8,000 | 520,800 | 108,490 | 100.5 K to 108.5 K (+7.96 %) |
Apr 25 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 65.10 | 8,000 | 520,800 | 1,744,065 | 1.7 M to 1.7 M (+0.46 %) |
Apr 25 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 65.10 | 8,000 | 520,800 | 63,479 | 55.5 K to 63.5 K (+14.42 %) |
Apr 25 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 65.10 | 8,000 | 520,800 | 173,213 | 165.2 K to 173.2 K (+4.84 %) |
Apr 25 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 65.10 | 8,000 | 520,800 | 214,800 | 206.8 K to 214.8 K (+3.87 %) |
Mar 07 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | P | 105.75 | 9,031 | 955,028 | 211,614 | 202.6 K to 211.6 K (+4.46 %) |
Mar 07 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | P | 105.75 | 365,969 | 38,701,222 | 8,172,521 | 7.8 M to 8.2 M (+4.69 %) |
Sep 27 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | P | 56.63 | 25,663 | 1,453,296 | 202,583 | 176.9 K to 202.6 K (+14.51 %) |
Sep 27 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | P | 56.63 | 1,024,337 | 58,008,204 | 7,806,552 | 6.8 M to 7.8 M (+15.10 %) |
Jun 10 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 40.32 | 15,000 | 604,800 | 15,000 | |
Jun 10 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 40.32 | 15,000 | 604,800 | 15,000 | |
Jun 10 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 40.32 | 15,000 | 604,800 | 15,000 | |
Jun 10 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 40.32 | 15,000 | 604,800 | 15,000 | |
Jun 10 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 40.32 | 15,000 | 604,800 | 15,000 | |
Jun 10 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 40.32 | 15,000 | 604,800 | 15,000 | |
Jun 10 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 40.32 | 15,000 | 604,800 | 15,000 | |
Jan 08 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | P | 47.53 | 20,099 | 955,305 | 176,920 | 156.8 K to 176.9 K (+12.82 %) |
Jan 08 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | P | 47.53 | 839,621 | 39,907,186 | 6,782,215 | 5.9 M to 6.8 M (+14.13 %) |
Jul 13 2012 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | P | 41.20 | 21,082 | 868,578 | 156,821 | 135.7 K to 156.8 K (+15.53 %) |
Jul 13 2012 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | P | 41.20 | 864,918 | 35,634,622 | 5,942,594 | 5.1 M to 5.9 M (+17.03 %) |
Jun 29 2012 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 40.74 | 7,500 | 305,550 | 7,500 | |
Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 2,350.00 | 1 | 2,350 | 1 | |
Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 2,350.00 | 1 | 2,350 | 1 | |
Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Grant | A | 0.00 | 135,462 | 0 | 143,962 | 8.5 K to 144 K (+1,593.67 %) |
Page: 1